Unknown

Dataset Information

0

Microarray profile of human kidney from diabetes, renal cell carcinoma and renal cell carcinoma with diabetes.


ABSTRACT: Recent study from our laboratory showed that patients with diabetes are at a higher risk of developing kidney cancer. In the current study, we have screened whole human DNA genome from healthy control, patients with diabetes or renal cell carcinoma (RCC) or RCC+diabetes. We found that 883 genes gain/163 genes loss of copy number in RCC+diabetes group, 669 genes gain/307 genes loss in RCC group and 458 genes gain/38 genes loss of copy number in diabetes group, after removing gain/loss genes obtained from healthy control group. Data analyzed for functional annotation enrichment pathways showed that control group had the highest number (280) of enriched pathways, 191 in diabetes+RCC group, 148 in RCC group, and 81 in diabetes group. The overlap GO pathways between RCC+diabetes and RCC groups showed that nine were enriched, between RCC+diabetes and diabetes groups was four and between diabetes and RCC groups was eight GO pathways. Overall, we observed majority of DNA alterations in patients from RCC+diabetes group. Interestingly, insulin receptor (INSR) is highly expressed and had gains in copy number in RCC+diabetes and diabetes groups. The changes in INSR copy number may use as a biomarker for predicting RCC development in diabetic patients.

SUBMITTER: Kosti A 

PROVIDER: S-EPMC4362485 | biostudies-literature | 2015 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

Microarray profile of human kidney from diabetes, renal cell carcinoma and renal cell carcinoma with diabetes.

Kosti Adam A   Harry Chen Hung-I HI   Mohan Sumathy S   Liang Sitai S   Chen Yidong Y   Habib Samy L SL  

Genes & cancer 20150101 1-2


Recent study from our laboratory showed that patients with diabetes are at a higher risk of developing kidney cancer. In the current study, we have screened whole human DNA genome from healthy control, patients with diabetes or renal cell carcinoma (RCC) or RCC+diabetes. We found that 883 genes gain/163 genes loss of copy number in RCC+diabetes group, 669 genes gain/307 genes loss in RCC group and 458 genes gain/38 genes loss of copy number in diabetes group, after removing gain/loss genes obtai  ...[more]

Similar Datasets

| S-EPMC7646169 | biostudies-literature
| S-EPMC6051088 | biostudies-literature
| S-EPMC6739217 | biostudies-literature
2003-11-25 | GSE781 | GEO
2003-11-25 | E-GEOD-781 | biostudies-arrayexpress
| S-EPMC442130 | biostudies-literature
| S-EPMC5156798 | biostudies-literature
| S-EPMC3060607 | biostudies-literature
| S-EPMC3412851 | biostudies-literature
| S-EPMC9468637 | biostudies-literature